Table 1.
Daily clinical and laboratory variables during ICU stay
Variables | Reference range | Day 1 admission | Day 3 | Day 7 | Day 10 | Day14 | Day21 | Day 28 | Day 40 | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SOFA | 13 | 16 | 16 | 16 | 17 | 16 | 15 | 13 | |||||||||||||||
White blood counts (per μl) | (4800–10,800) | 5,700 | 11,710 | 9990 | 8760 | 17,070 | 27,930 | 23,750 | 10,710 | ||||||||||||||
Lymphocytes(per μl) | (900–5200) | 1000 | 700 | 800 | 400 | 800 | 1,200 | 800 | 1800 | ||||||||||||||
Neutrophils (per μl) | (1900–8000) | 4,300 | 10,300 | 8,500 | 7700 | 12,600 | 23,600 | 21,100 | 6300 | ||||||||||||||
N/L | 4.3 | 14.7 | 10.6 | 19.2 | 15.7 | 19.6 | 26.3 | 3.5 | |||||||||||||||
CRP (mg/dl) | (0–1) | 17.7 | 31.9 | 18.6 | 14.3 | 25 | 17.1 | 8.65 | 8.80 | ||||||||||||||
Procalcitonin(ng/ml) | (0–0.5) | 1.9 | 13 | 7.92 | 6.91 | 13.1 | 10 | 6.06 | 5.75 | ||||||||||||||
Glycemia (mg/dl) | (60–99) | 124 | 96 | 96 | 70 | 92 | 96 | 86 | 96 | ||||||||||||||
D-dimer (mg/l) | (0–0.5) | 1.9 | 4.3 | 0.8 | 1 | 2.6 | 2.7 | 6.1 | 7.64 | ||||||||||||||
Ferritin (ng/ml) | (26–388) | 3216 | 3755 | 2012 | 1395 | 2128 | 2737 | 2084 | – | ||||||||||||||
NT-proBNP (pg/ml) | (0–125) | 653 | 2147 | 2869 | 2801 | 3028 | 12,541 | 26,116 | 19,692 | ||||||||||||||
PaO2/FiO2 | 190 | 197 | 208 | 174 | 130 | 161 | 189 | 260 | |||||||||||||||
SARS-CoV-2 RT-PCR | Positive | Positive | Positive | Positive | Negative Negative after 24 h | Negative | |||||||||||||||||
BAS/BAL | Rhizopus spp. | Rhizopus spp. | Rhizopus spp. | Rhizopus spp. | |||||||||||||||||||
Pleural effusion | Histo-pathology | Negative | |||||||||||||||||||||
Microbio-logy | Negative |
SOFA sequential organ failure assessment, N/L neutrophils/lymphocyte ratio, CRP C-reactive protein